{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:44:54Z","timestamp":1775079894611,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jvacx.2024.100544","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T03:11:22Z","timestamp":1722654682000},"page":"100544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Logistic and organizational barriers to herpes zoster vaccination in europe: A systematic review"],"prefix":"10.1016","volume":"20","author":[{"given":"Michele","family":"Sorrentino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Belpiede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Fiorilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelangelo","family":"Mercogliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Triassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffale","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jvacx.2024.100544_b0010","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella\u2013zoster vaccine for the prevention of herpes zoster","volume":"356","author":"Kimberlin","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100544_b0015","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/infdis\/jiz652","article-title":"The epidemiology of herpes zoster in immunocompetent, unvaccinated adults \u226550 years old: incidence, complications, hospitalization, mortality, and recurrence","volume":"222","author":"Tseng","year":"2020","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100544_b0020","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"16","key":"10.1016\/j.jvacx.2024.100544_b0025","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","article-title":"Postherpetic Neuralgia","volume":"371","author":"Johnson","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100544_b0030","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/21645515.2015.1016681","article-title":"Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status","volume":"11","author":"Marin","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100544_b0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14760584.2019.1646129","article-title":"Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States","volume":"18","author":"Harpaz","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"Supplement_4","key":"10.1016\/j.jvacx.2024.100544_b0040","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","article-title":"\u201cHerpes zoster vaccines\u201d","volume":"224","author":"Harbecke","year":"2021","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100544_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/hv.34363","article-title":"Reducing the burden of herpes zoster in italy","volume":"11","author":"Gabutti","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100544_b0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12889-015-1514-y","article-title":"The humanistic, economic and societal burden of Herpes Zoster in Europe: a critical review","volume":"15","author":"Gater","year":"2015","journal-title":"BMC Public Health"},{"issue":"12","key":"10.1016\/j.jvacx.2024.100544_b0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2146\/ajhp170399","article-title":"Herpes zoster subunit vaccine for the prevention of herpes zoster","volume":"75","author":"Symoniak","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jvacx.2024.100544_b0060","article-title":"Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review","volume":"10","author":"Pan","year":"2022","journal-title":"Ther Adv Vaccines Immunother"},{"issue":"22","key":"10.1016\/j.jvacx.2024.100544_b0065","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jvacx.2024.100544_b0070","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100544_b0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12879-017-2445-2","article-title":"Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization","volume":"17","author":"Riera-Montes","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100544_b0080","unstructured":"Centers for Disease Control and Prevention, \u201cShingles (Herpes Zoster),\u201d https:\/\/www.cdc.gov\/shingles\/index.html."},{"issue":"1","key":"10.1016\/j.jvacx.2024.100544_b0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1086\/320884","article-title":"Characteristics of patients with herpes zoster on presentation to practitioners in france","volume":"33","author":"Chidiac","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100544_b0090","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/21645515.2020.1788861","article-title":"Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study","volume":"17","author":"Soysal","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.jvacx.2024.100544_b0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciy953","article-title":"The epidemiology of herpes zoster in the united states during the era of varicella and herpes zoster vaccines: Changing Patterns among older adults","volume":"69","author":"Harpaz","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100544_b0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMcp1302674","article-title":"Herpes zoster","volume":"369","author":"Cohen","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100544_b0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/2051013615599151","article-title":"Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective","volume":"3","author":"Johnson","year":"2015","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.jvacx.2024.100544_b0110","unstructured":"WHO, \u201cVaricella and herpes zoster vaccines: WHO position paper,\u201d Weekly epidemiological record, vol. 89, no. 25, pp. 265\u2013288, Jun. 2014."},{"key":"10.1016\/j.jvacx.2024.100544_b0115","unstructured":"European Centre for Disease Prevention and Control, \u201cVaccine schedules in all countries in the EU\/EEA,\u201d https:\/\/vaccine-schedule.ecdc.europa.eu."},{"issue":"11","key":"10.1016\/j.jvacx.2024.100544_b0120","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1080\/21645515.2021.1960137","article-title":"Low willingness to vaccinate against herpes zoster in a Chinese metropolis","volume":"17","author":"Lu","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100544_b0125","doi-asserted-by":"crossref","first-page":"e004206","DOI":"10.1136\/bmjgh-2020-004206","article-title":"Social media and vaccine hesitancy","volume":"5","author":"Wilson","year":"2020","journal-title":"BMJ Glob Health"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100544_b0130","doi-asserted-by":"crossref","first-page":"e0276082","DOI":"10.1371\/journal.pone.0276082","article-title":"On the relationship between conspiracy theory beliefs, misinformation, and vaccine hesitancy","volume":"17","author":"Enders","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jvacx.2024.100544_b0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/1469-0691.12447","article-title":"Barriers to the vaccination of children and adolescents and possible solutions","volume":"20","author":"Esposito","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100544_b0140","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jvacx.2024.100544_b0145","unstructured":"European Medicines Agency, \u201cShingrix Overview,\u201d https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/shingrix#:\u223c:text=News%20on%20Shingrix-,Overview,increased%20risk%20of%20herpes%20zoster."},{"key":"10.1016\/j.jvacx.2024.100544_b0150","unstructured":"https:\/\/www.rayyan.ai\/, \u201cRayyan. Intelligent Systematic Review.\u201d."},{"issue":"12","key":"10.1016\/j.jvacx.2024.100544_b0155","doi-asserted-by":"crossref","first-page":"e011458","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100544_b0160","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3390\/vaccines10101770","article-title":"Adherence to herpes zoster (Shingles) catch-up campaign at the romagna local health authority (Italy), a multi-center retrospective observational study","volume":"10","author":"Ceccarelli","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"26","key":"10.1016\/j.jvacx.2024.100544_b0165","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.vaccine.2021.04.062","article-title":"Older adults\u2019 vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake","volume":"39","author":"Nicholls","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100544_b0170","doi-asserted-by":"crossref","first-page":"e0220230","DOI":"10.1371\/journal.pone.0220230","article-title":"Determinants of shingles vaccine acceptance in the United Kingdom","volume":"14","author":"Bricout","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jvacx.2024.100544_b0175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.vaccine.2008.10.047","article-title":"Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly","volume":"27","author":"Opstelten","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100544_b0180","doi-asserted-by":"crossref","DOI":"10.12809\/hkmj165043","article-title":"A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting","author":"Lam","year":"2017","journal-title":"Hong Kong Med J"},{"issue":"9","key":"10.1016\/j.jvacx.2024.100544_b0185","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14760584.2021.1954910","article-title":"Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among chinese aged 50\u201369 years","volume":"20","author":"Lu","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100544_b0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1529100618760521","article-title":"Increasing vaccination: Putting psychological science into action","volume":"18","author":"Brewer","year":"2017","journal-title":"Psychol Sci Public Interest"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100544_b0195","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/605430","article-title":"Immunization programs for infants, children, adolescents, and adults: Clinical practice guidelines by the infectious diseases society of america","volume":"49","author":"Pickering","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jvacx.2024.100544_b0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the use of herpes zoster vaccine","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"issue":"s2","key":"10.1016\/j.jvacx.2024.100544_b0205","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1086\/522153","article-title":"National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine","volume":"197","author":"Hurley","year":"2008","journal-title":"J Infect Dis"},{"issue":"52","key":"10.1016\/j.jvacx.2024.100544_b0210","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1016\/j.vaccine.2020.11.002","article-title":"Understanding immunosenescence and its impact on vaccination of older adults","volume":"38","author":"Allen","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jvacx.2024.100544_b0215","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1016\/j.vaccine.2024.03.024","article-title":"Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021\u201323","volume":"42","author":"Stefanizzi","year":"2024","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100544_b0220","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/cid\/ciab125","article-title":"Recombinant zoster vaccine (Shingrix): Real-world effectiveness in the first 2 years post-licensure","volume":"73","author":"Izurieta","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jvacx.2024.100544_b0225","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/653605","article-title":"Zoster vaccine: Current status and future prospects","volume":"51","author":"Oxman","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Supplement_5","key":"10.1016\/j.jvacx.2024.100544_b0230","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckaa165.615","article-title":"Organisational barriers to accessing vaccination services: a literature overview focusing on underserved populations in Europe","volume":"vol. 30","author":"Jansen","year":"2020","journal-title":"Eur J Public Health"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100544_b0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13643-022-01941-4","article-title":"Strategies to overcome vaccine hesitancy: a systematic review","volume":"11","author":"Singh","year":"2022","journal-title":"Syst Rev"},{"key":"10.1016\/j.jvacx.2024.100544_b0240","unstructured":"European Medicines Agency, \u201cZostavax,\u201d https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zostavax."}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T19:29:19Z","timestamp":1729020559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"alternative-id":["S2590136224001177"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100544","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Logistic and organizational barriers to herpes zoster vaccination in europe: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100544"}}